The latest price target for OS Therapies (AMEX:OSTX) was reported by Maxim Group on November 26, 2024. The analyst firm set a price target for $8.00 expecting OSTX to rise to within 12 months (a possible 266.45% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for OS Therapies (AMEX:OSTX) was provided by Maxim Group, and OS Therapies initiated their buy rating.

There is no last upgrade for OS Therapies

There is no last downgrade for OS Therapies.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OS Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OS Therapies was filed on November 26, 2024 so you should expect the next rating to be made available sometime around November 26, 2025.

While ratings are subjective and will change, the latest OS Therapies (OSTX) rating was a initiated with a price target of $0.00 to $8.00. The current price OS Therapies (OSTX) is trading at is $2.18, which is within the analyst’s predicted range.